These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 27618021)

  • 21. Making paediatric precision oncology a reality.
    The Lancet Oncology
    Lancet Oncol; 2016 Oct; 17(10):1335. PubMed ID: 27733256
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacogenomics in pediatrics: personalized medicine showing eminent promise.
    Mele C; Goldschmidt K
    J Pediatr Nurs; 2014; 29(4):378-82. PubMed ID: 24880100
    [No Abstract]   [Full Text] [Related]  

  • 23. Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.
    Russo R; Capasso M; Paolucci P; Iolascon A;
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1():17-27. PubMed ID: 21069522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".
    Capitini CM; Gottschalk S; Brenner M; Cooper LJ; Handgretinger R; Mackall CL
    Pediatr Hematol Oncol; 2011 Sep; 28(6):459-60. PubMed ID: 21854215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complementary and alternative therapies in pediatric oncology.
    Sencer SF; Kelly KM
    Pediatr Clin North Am; 2007 Dec; 54(6):1043-60; xiii. PubMed ID: 18061790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of Supportive Care Pharmacogenomics in Oncology Practice.
    Patel JN; Wiebe LA; Dunnenberger HM; McLeod HL
    Oncologist; 2018 Aug; 23(8):956-964. PubMed ID: 29622698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic testing: proofs of principle and pharmacoeconomic implications.
    Dervieux T; Meshkin B; Neri B
    Mutat Res; 2005 Jun; 573(1-2):180-94. PubMed ID: 15829247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinically relevant pharmacogenomic testing in pediatric practice.
    Korbel L; George M; Kitzmiller J
    Clin Pediatr (Phila); 2014 Aug; 53(9):831-8. PubMed ID: 24803633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe.
    van den Akker-van Marle ME; Gurwitz D; Detmar SB; Enzing CM; Hopkins MM; Gutierrez de Mesa E; Ibarreta D
    Pharmacogenomics; 2006 Jul; 7(5):783-92. PubMed ID: 16886902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics of serious adverse drug reactions in pediatric oncology.
    Ross CJ; Visscher H; Rassekh SR; Castro-Pastrana LI; Shereck E; Carleton B; Hayden MR
    J Popul Ther Clin Pharmacol; 2011; 18():e134-51. PubMed ID: 21467604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives.
    Seifert G; Budach V; Keilholz U; Wust P; Eggert A; Ghadjar P
    Radiat Oncol; 2016 Apr; 11():65. PubMed ID: 27138749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurosurgical perspectives in pediatric neurooncology.
    Tomita T
    Childs Nerv Syst; 1998 Mar; 14(3):94-6. PubMed ID: 9579861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and population pharmacokinetics in pediatric oncology.
    Sassen SDT; Zwaan CM; van der Sluis IM; Mathôt RAA
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28132. PubMed ID: 31876123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European Society of Medical Oncology 2018 Congress.
    Sklan A
    Lancet Oncol; 2018 Dec; 19(12):e678. PubMed ID: 30509886
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer pharmacogenomics in children: research initiatives and progress to date.
    Rassekh SR; Ross CJ; Carleton BC; Hayden MR
    Paediatr Drugs; 2013 Apr; 15(2):71-81. PubMed ID: 23529868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric perspective on pharmacogenomics.
    Stevens A; De Leonibus C; Hanson D; Whatmore A; Murray P; Donn R; Meyer S; Chatelain P; Clayton P
    Pharmacogenomics; 2013 Nov; 14(15):1889-905. PubMed ID: 24236488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implementation of pharmacogenetics.
    García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
    Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age span challenges: adherence in pediatric oncology.
    Landier W
    Semin Oncol Nurs; 2011 May; 27(2):142-53. PubMed ID: 21514483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.